US Patent Issued to HANGZHOU NORMAL UNIVERSITY on July 28 for "Dual-targeting biomimetic liposome with elemene (ELE) and cabazitaxel (CTX), and preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,066, issued on July 28, was assigned to HANGZHOU NORMAL UNIVERSITY (Hangzhou, China).

"Dual-targeting biomimetic liposome with elemene (ELE) and cabazitaxel (CTX), and preparation method and use thereof" was invented by Tian Xie (Hangzhou, China), Yiying Zeng (Hangzhou, China), Jie Li (Hangzhou, China) and Zhaowu Zeng (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a dual-targeting biomimetic liposome with elemene (ELE) and cabazitaxel (CTX), where each 100 mL of the dual-targeting biomimetic liposome with ELE and CTX includes 0.15 g to 0.75 g of the ELE, 0.5 mL to 2.5 mL of absolute ethanol, 0.015 g t...